Median Nerve Thickness of the Carpal Tunnel Syndrome After Two Different Physiotherapy Modalities

NCT ID: NCT07167667

Last Updated: 2025-09-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-25

Study Completion Date

2025-10-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study plans to include a total of 60 patients diagnosed with carpal tunnel syndrome. Patients will be divided into two groups according to the treatment they receive. One group will receive only paraffin treatment, while the other group will receive only ESWT treatment. ESWT will be applied for a total of 5 sessions. Paraffin will be applied for a total of 10 sessions. As assessment tools;

* Measurement of median nerve thickness with ultrasound
* Electromyography
* Visual Analog Scale
* Short Form-36

Evaluations will be made twice by a specialist physician before and after the treatments.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carpal Tunnel Syndrome (CTS)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Paraffin

Group Type EXPERIMENTAL

Paraffin Bath

Intervention Type OTHER

Patients' hands will be dipped into the paraffin bath 8-10 times.

ESWT

Group Type EXPERIMENTAL

Extracorporeal Shock Wave Therapy

Intervention Type OTHER

The patients will be treated with a sound wave pulse frequency of 15 Hz, an intensity of 1.5 bar, and a total number of pulses of 2000 for one session.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Paraffin Bath

Patients' hands will be dipped into the paraffin bath 8-10 times.

Intervention Type OTHER

Extracorporeal Shock Wave Therapy

The patients will be treated with a sound wave pulse frequency of 15 Hz, an intensity of 1.5 bar, and a total number of pulses of 2000 for one session.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals between the ages of 30-60 who have been diagnosed with CTS by a specialist physician according to international criteria (Those between Stages 1-3),
* Those who have complaints of numbness, tingling, and pain in the first three fingers and half of the fourth finger,
* Phalen Test and Tinel sign or Durkan Test being positive
* Patients who will receive 5 sessions of ESWT application prescribed by a Physical Medicine and Rehabilitation Specialist Physician (for the ESWT group)
* Patients who have been recommended 10 sessions of Paraffin application by a Physical Medicine and Rehabilitation Specialist Physician (for the Paraffin group)

Exclusion Criteria

* Presence of atrophy in the thenar muscles,
* Insufficient sensory and motor response in the median nerve,
* History of hand and/or wrist injury or surgery,
* Those with cervical stenosis, cervical spondylosis, or cervical radiculopathy,
* Corticosteroids in the carpal tunnel area within the last six months those who have had an injection,
* Pregnancy or diabetes, renal failure, rheumatoid arthritis or hypothyroidism
Minimum Eligible Age

30 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Emre Şenocak

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emre Şenocak

Assistant Professor

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Baltalimani Metin Sabanci Bone Diseases Training and Research Hospita

Istanbul, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Esra Sonbahar Bolat, Physician

Role: CONTACT

+9005052686709

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Esra Sonbahar Bolat, Physican

Role: primary

+905052686709

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024/145

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.